Patient
SITE001-0066
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE001 (USA) (Dr. Reyes)
consented 2025-11-22
Adverse events
6
Serious AEs
1
Open data queries
1
Luna dropout signal
+0.25
Adverse events 6
Participant-reported via Luna chat: "I've had some nausea since yesterday evening". Solicited symptom report logged for the next visit review.
Participant-reported via Luna chat: "severe shortness of breath and chest pain since this morning". Solicited symptom report; requires clinical characterization.
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-03-01 (study day 280); relationship: RELATED
Grade 2 Asthenia — outcome: RECOVERED/RESOLVED; onset 2022-11-17 (study day 176); relationship: NOT RELATED
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-11-01 (study day 160); relationship: NOT RELATED
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2022-08-11 (study day 78); relationship: not assessed
Data queries 1
AE Adverse event (serious) for SITE001-0066 (onset undated) is flagged serious but no seriousness criterion (death, life-threatening, hospitalization, disability, congenital anomaly, other) is recorded.
Luna engagement
Messages
4
Escalations
0
Check-ins
2
last 2026-09-19
Mood ø
2.5
of 5
Adherence · 7d
0%